Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Marco Safadi"'
Autor:
Neal Halsey, Stephen Evans, Mathuram Santosham, Adam Hacker, Kathryn M. Edwards, Rebecca E. Chandler, Matthew Z. Dudley, Cornelia L. Dekker, Seif Al-Abri, Narendra Arora, Jim Buttery, Alex Dodoo, Juhani Eskola, Ulrich Heininger, Youngmee Jee, Najwa Khuri, Stephen Obaro, Walt Orenstein, Punnee Pitisuttithum, Marco Safadi, Cynthia G. Whitney, Steve Black
Publikováno v:
Vaccine. 41:3399-3402
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2ac1270337cd2aa8f8448551252dd917
https://doi.org/10.1016/j.vaccine.2023.04.033
https://doi.org/10.1016/j.vaccine.2023.04.033
Autor:
Marco Safadi
Publikováno v:
J Pediatr (Rio J)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8e6013a38448c0aeca86909cd8862c0
https://doi.org/10.1016/j.jped.2022.12.003
https://doi.org/10.1016/j.jped.2022.12.003
Publikováno v:
Revista Paulista de Pediatria, Vol 39 (2020)
Revista Paulista de Pediatria
Revista Paulista de Pediatria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa563131ad78caf64343d5cdd0b3e42d
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-05822021000100101&tlng=pt
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-05822021000100101&tlng=pt
Publikováno v:
Pediatrics. 134:e620-e638
Guidance from the American Academy of Pediatrics (AAP) for the use of palivizumab prophylaxis against respiratory syncytial virus (RSV) was first published in a policy statement in 1998. Guidance initially was based on the result from a single random
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d93bc7d54c80ccccb09d4bfa35d2781
https://doi.org/10.1542/peds.2014-1666
https://doi.org/10.1542/peds.2014-1666
Autor:
Marco Aurélio Palazzi Sáfadi, Johan Holst, Muhamed-Kheir Taha, Anne von Gottberg, Lee H. Harrison, Annelies Wilder-Smith, Stanley A. Plotkin, Ray Borrow, Julio A. Vázquez, Stephen I. Pelton, F. Marc LaForce
Publikováno v:
Vaccine
Vaccine, 2011, 29 (18), pp.3363-3371. ⟨10.1016/j.vaccine.2011.02.058⟩
Vaccine, Elsevier, 2011, 29 (18), pp.3363-3371. ⟨10.1016/j.vaccine.2011.02.058⟩
Vaccine, 2011, 29 (18), pp.3363-3371. ⟨10.1016/j.vaccine.2011.02.058⟩
Vaccine, Elsevier, 2011, 29 (18), pp.3363-3371. ⟨10.1016/j.vaccine.2011.02.058⟩
International audience; The Global Meningococcal Initiative (GMI) is composed of an international group of scientists, clinicians and public health officials with expertise in meningococcal immunology, epidemiology and prevention. The primary goal of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e27b48041e8a32294f3a667d08ae1b5
https://hal-pasteur.archives-ouvertes.fr/pasteur-02083011
https://hal-pasteur.archives-ouvertes.fr/pasteur-02083011
